Notice2023-03798
Notice To Announce Updated Minimum Performance Standards for Experienced Firms That Receive Funding Through the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Programs
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
February 24, 2023
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Abstract
The National Institutes of Health (NIH) announces the updated minimum performance standards for experienced firms funded through the Department of Health and Human Services (HHS) Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Programs.
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 37 (Friday, February 24, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 37 (Friday, February 24, 2023)]
[Notices]
[Page 11927]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-03798]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Notice To Announce Updated Minimum Performance Standards for
Experienced Firms That Receive Funding Through the Small Business
Innovation Research (SBIR) and Small Business Technology Transfer
(STTR) Programs
AGENCY: National Institutes of Health, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The National Institutes of Health (NIH) announces the updated
minimum performance standards for experienced firms funded through the
Department of Health and Human Services (HHS) Small Business Innovation
Research (SBIR) and Small Business Technology Transfer (STTR) Programs.
DATES: The relevant funding opportunity announcements have been updated
to incorporate these changes. The updated performance standards will be
required of any firms submitting SBIR or STTR grant or cooperative
agreement applications on or after April 5, 2023.
ADDRESSES: Please visit our website to view the updated Minimum
Performance Standards for Experienced Firms at <a href="https://seed.nih.gov/small-business-funding/small-business-program-basics/eligibility-criteria">https://seed.nih.gov/small-business-funding/small-business-program-basics/eligibility-criteria</a>.
FOR FURTHER INFORMATION CONTACT: Stephanie Fertig, HHS Small Business
Program Lead, Small business Education & Entrepreneurial Development
(SEED) Office, Office of Extramural Research, NIH, Rockledge I, Suite
800, Bethesda, MD 20817. Email: <a href="/cdn-cgi/l/email-protection#e4978181808d8a828ba48a8d8cca838b92"><span class="__cf_email__" data-cfemail="57243232333e39313817393e3f79303821">[email protected]</span></a>. Phone number (301)
435-2688.
SUPPLEMENTARY INFORMATION: The new minimum standards are aligned with
Section 9 of the Small Business Act (15 U.S.C. 638), as amended by the
SBIR and STTR Extension Act of 2022 (Pub. L. 117-183).
HHS is announcing the following changes:
Phase I to Phase II Transition Rate Benchmark: In accordance with
guidance from the SBA, the HHS SBIR/STTR Program is implementing the
Phase I to Phase II Transition Rate benchmark required by the SBIR/STTR
Reauthorization Act of 2011 and the SBIR and STTR Extension Act of
2022. The benchmark establishes a minimum number of Phase II awards the
company must have received for a given number of Phase I awards
received during the 5-year time period. The Transition Rate is
calculated as the total number of SBIR and STTR Phase II awards a
company received during the past 5 fiscal years divided by the total
number of SBIR and STTR Phase I awards it received during the past 5
fiscal years excluding the most recently-completed year.
Phase II to Commercialization Benchmark: In accordance with
guidance from the SBA, HHS, including NIH, SBIR/STTR Programs are
implementing the Phase II to Commercialization Rate benchmark for Phase
I applicants, as required by the SBIR/STTR Reauthorization Act of 2011
and the SBIR and STTR Extension Act of 2022. The Commercialization Rate
Benchmark was published in a Federal Register notice on August 8, 2013
(78 FR 48537).
This update is applicable to all HHS SBIR and STTR grants and
cooperative agreements with application receipt dates on or after April
5, 2023. This update supersedes, in its entirety, previous Phase I to
Phase II transition benchmarks established in May 2013 (78 FR 30951)
and previous Commercialization Benchmarks established in September 2013
(78 FR 59410). Additional information can be found at: <a href="https://grants.nih.gov/grants/guide/notice-files/not-od-23-092.htm">https://grants.nih.gov/grants/guide/notice-files/not-od-23-092.htm</a>.
Dated: February 16, 2023.
Tara A. Schwetz,
Acting Principal Deputy Director, National Institutes of Health.
[FR Doc. 2023-03798 Filed 2-23-23; 8:45 am]
BILLING CODE 4140-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on February 24, 2023.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.